Paradigm Biocapital Advisors LP Iveric Bio, Inc. Transaction History

Paradigm Biocapital Advisors LP

  • $2.67 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$9.12 - $18.9 $8.3 Million - $17.2 Million
-910,416 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$12.15 - $16.83 $1.15 Million - $1.6 Million
94,835 Added 11.63%
910,416 $15.3 Million
Q4 2021

Feb 14, 2022
BUY
$13.83 - $18.78 $11.3 Million - $15.3 Million
815,581 New
815,581 $13.6 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Paradigm Biocapital Advisors LP Portfolio

Follow Paradigm Biocapital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Biocapital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Biocapital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email